PSI South Africa

Overview

PSI South Africa’s vision is to create a financially viable enterprise that optimizes health impact by developing targeted solutions that increase consumer choice and access to quality, affordable health products. PSI South Africa started as a condom business in 2012 and has begun to expand into pharmaceuticals as of 2017. As an enterprise, PSI South Africa’s geographic reach extends beyond South Africa itself to include Lesotho, Eswatini, Namibia, Botswana, Zambia and Zimbabwe.

For all official information and updates regarding COVID-19, visit the South African Department of Health’s website at www.SAcoronavirus.co.za

Why Social Enterprise?

PSI expands access to low-cost, high quality products through the PSI South Africa regional social enterprise, which extends across southern Africa. It aims to address consumers’ health needs at scale and leverages regional operational efficiencies to deliver long-term, financially sustainable health impact. Through PSI South Africa, PSI shows that the private sector has the potential to fulfill important health needs for populations underserved by the public sector.

PSI South Africa’s
Health Areas

01
Asset 8

Sexual and
Reproductive Health

02
Asset 25

HIV/AIDS

Our Approach

Historically, PSI South Africa has always taken an enterprise-style approach to global health challenges, coupling donor funding with marketing, the use of branded products and consumer insights from the private sector. Now, PSI is leveraging this approach in in markets that can support social enterprises to fulfill donor expectations for more sustainable approaches. PSI uses sound marketing and business discipline in its social enterprises to ensure the long-term viability of consumer-powered healthcare by balancing the pursuit of social impact and financial self-reliance.

Our
Impact

PSI South Africa has achieved the following impact for its clients:

2.5 million

years of protection against unintended pregnancy provided for the couples it serves

7 million

years of healthy life provided for its clients

Our
Leadership

Grace Bryson

Regional Regulatory Affairs and Quality Assurance Executive PSI South Africa

Sibongile Mngadi

Pharmaceutical Executive PSI South Africa

Gauta Mavundla

Managing Executive PSI South Africa

Latest
Updates

Discover what's happening at PSI

1 constant in the 12 months since COVID

There’s been 1 constant in the 12 months since COVID started: women and girls’ health priorities do not pause for a pandemic. Amidst COVID, we’ve

+ Read More

Equity and Equality in Global Health: Making Our Way

By Karl Hofmann, PSI President & CEO  “On behalf of Global Health 50/50, we would like to congratulate PSI for their strong performance in the

+ Read More

Her Journey, Her Choice

This piece was originally featured on the DISC microsite blog. By Abigail Winskell, DISC Deputy Director. It might seem obvious that the development of sexual and reproductive health options, including self-injectable

+ Read More

Preventing Malaria in Pregnancy in Mali

This piece was originally featured on the PMI Impact Malaria blog. Written by Katherine Kemp, PMI Impact Malaria Communications Coordinator. Contributions from Samba Coumaré and Cheick Traore, PMI

+ Read More

PSI welcomes fearless leader Michele Goodwin to Board of Directors

January 2021 marked the exciting start of the latest term for PSI’s Board of Directors. So began the tenure of four new and returning talented Board members and new Board Chair Carolyn Brehm. We are conducting interviews with the

+ Read More

Why Self-care? Why Now?

Originally featured on the Self-Care Trailblazer Group blog. On 18 February 2021, more than 180 participants across 39 countries and from 75 different organizations tuned

+ Read More